Results 101 to 110 of about 15,628 (311)

Effects of GLP‐1 Receptor Agonists on Hair Loss and Regrowth: A Systematic Review

International Journal of Dermatology, EarlyView.
Miranda K. Branyiczky, Megan S. Lowe, Eric McMullen, Jeffrey Donovan, Touraj Khosravi‐Hafshejani   +4 more
wiley   +1 more source

Glucagon‐Like Peptide‐1 Analogues and the Risk of Recurrent Pancreatitis in Diabetic Patients With History of Pancreatitis or Elevated Lipase: Retrospective Cohort Analysis

Diabetes/Metabolism Research and Reviews, Volume 42, Issue 1, January 2026.
ABSTRACT Aims The use of glucagon‐like peptide‐1 (GLP1) analogues has increased due to benefits in glycaemic control, weight loss, and cardiorenal protection. However, concerns persist regarding their potential link to pancreatitis. We assessed this link in high‐risk patients with a history of pancreatitis or elevated lipase enzyme.
Bronya Calvarysky, Yaara Gal, Shiri Kushnir, Adi Turjeman, Tzippy Shochat, Idit Dotan, Talia Diker Cohen   +6 more
wiley   +1 more source

Drug-induced interstitial lung disease: a real-world pharmacovigilance study of the FDA Adverse Event Reporting System from 2004 to 2021

Therapeutic Advances in Drug Safety
Background: Drug-induced interstitial lung disease (DILD) is an increasingly common cause of morbidity and mortality. However, due to the lack of specificity, DILD detection remains an unsolved public health challenge.
Tingting Jiang, Hui Su, Jing Xu, Chen Li, Ni Zhang, Yanping Li, Yuanlin Wu, Rui Ni, Yue Ming, Ziwei Li, Li Li, Yao Liu   +11 more
doaj   +1 more source

Aspirin in the Food and Drug Administration Adverse Event Reporting System: Missing Demographics and Underreporting

TH Open, 2017
Background The U.S. Food and Drug Administration (FDA) Adverse Event (AE) Reporting System (FAERS) is a global passive surveillance repository requiring mandatory updates by pharmaceutical manufacturers. Oral antiplatelet agents (OAAs) including aspirin (
Victor L. Serebruany, Ales Tomek, Moo Hyun Kim, Oleg Litvinov, Thomas A. Marciniak   +4 more
doaj   +1 more source

Neuropsychiatric Outcomes of IL‐17 and IL‐23 Inhibitors in Dermatology: Risks, Benefits, and Clinical Implications

International Journal of Dermatology, EarlyView.
Isabella J. Tan, Alexis Mitelman, Mohammad Jafferany   +2 more
wiley   +1 more source

The First Case of Bacillus Calmette‐Guérin‐Induced Autoimmune Encephalitis

IJU Case Reports, Volume 9, Issue 1, January 2026.
ABSTRACT Introduction Intravesical bacillus Calmette‐Guerin (BCG) therapy is a standard treatment for intermediate to high‐risk non‐muscle invasive bladder cancer. While local side effects are common, systemic complications are rare and can be serious.
Makoto Ishii, Haruto Honda, Seigo Machiya, Hiromu Horitani, Sayaka Horii, Masao Kobayashi, Yutaka Ono   +6 more
wiley   +1 more source

Broadening the capture of natural products mentioned in FAERS using fuzzy string-matching and a Siamese neural network

Scientific Reports
Increased sales of natural products (NPs) in the US and growing safety concerns highlight the need for NP pharmacovigilance. A challenge for NP pharmacovigilance is ambiguity when referring to NPs in spontaneous reporting systems.
Israel O. Dilán-Pantojas, Tanupat Boonchalermvichien, Sanya B. Taneja, Xiaotong Li, Maryann R. Chapin, Sandra Karcher, Richard D. Boyce   +6 more
doaj   +1 more source

Pre‐Therapeutic UGT1A1 Genotyping in Breast Cancer Patients Receiving Sacituzumab Govitecan to Improve Safety: A Meta‐Analysis and Recommendation

Clinical and Translational Science, Volume 19, Issue 1, January 2026.
ABSTRACT Pre‐therapeutic UGT1A1 genotyping is increasingly performed in patients receiving irinotecan, as its active metabolite SN‐38 is primarily cleared through UGT1A1‐mediated glucuronidation. Patients with the UGT1A1*28/*28 genotype exhibit reduced UGT1A1 activity, leading to increased SN‐38 exposure and a higher risk of adverse events such as ...
Tessa Goedhart, Henk‐Jan Guchelaar
wiley   +1 more source

Phase diagram and aggregation dynamics of a monolayer of paramagnetic colloids

, 2017
We have developed a tunable colloidal system and a corresponding simulation model for studying the phase behavior of particles assembling under the influence of long-range magnetic interactions.
Charbonneau, Patrick, Detwiler, Paige, Pham, An T., Socolar, Joshua E. S., Yellen, Benjamin B., Zhuang, Yuan   +5 more
core   +1 more source

Safety of lifitegrast: A real-world pharmacovigilance study based on FAERS

PLoS ONE
To comprehensively assess the safety of Lifitegrast, a drug for dry eye disease, we conducted a comprehensive analysis of adverse event (AE) reports from the FDA Adverse Event Reporting System (FAERS).
Chu Zhang, Hui Wang, Xiang Chen, Yong Liu, Puen Jiang   +4 more
semanticscholar   +1 more source